About us
We are an innovative biotech startup headquartered in Bucharest, Romania, with a mission to advance cutting-edge research at the intersection of molecular biology, genetic engineering, and computational science. Our team was originally formed within the Systems biology of Aging academic group and brings together a multidisciplinary group of scientists with extensive expertise in molecular and cellular biology, proteomics, genome editing, bioinformatics, and systems biology. CellFabrik is committed to conducting high-impact applied research in biotechnology, leveraging both in silico and wet-lab approaches across a range of experimental models, including cellular and animal systems. Our primary areas of focus include the biology of aging and longevity, age-related diseases, cellular therapies, alternative protein sources, and early-stage drug discovery. Through the integration of bioinformatics-driven discovery pipelines and state-of-the-art molecular tools, we aim to identify novel genetic targets, biomarkers, and therapeutic strategies with strong translational potential. We are proud to maintain active collaborations with a network of esteemed research institutes, academic institutions, and clinical centers, which strengthen our scientific foundation and accelerate the development of innovative biotechnological solutions
Cellfabrik Team
Bogdan Micu
CEO, Business Development
Bogdan is an experienced entrepreneur in the fields of IT and Energy and was awarded Entrepreneur of the Year by PricewaterhouseCoopers (PwC). He has extensive experience in the growth and development of companies in both emerging and established markets, with a particular focus on the US market. Currently, Bogdan is steering the CellFabrik projects towards a successful outcome. He is also known for his role as an investor on the Romanian version of 'Shark Tank,' a television show dedicated to entrepreneurs, broadcasted by ProTV.
Robi Tacutu, PhD
CSO, Administration, Scientific Management
Robi is a scientist and entrepreneur with over 15 years of experience in aging research, systems biology, bioinformatics, and molecular biology. His educational background includes both Computer Science (BSc) and Life/Medical Sciences (MSc/PhD). Following his PhD at Ben-Gurion University in Israel and a postdoctoral position at the University of Liverpool in the UK, Robi secured a 2 million EUR grant to establish a research group at the Institute of Biochemistry in Bucharest. He has authored scientific papers covering a broad range of topics, from aging to bioinformatics and machine learning. He remains actively involved in both academia and industry.
Dmitri Toren, PhD
CTO, Operations, Senior Researcher
Dmitri earned his PhD in Medical Sciences from Ben-Gurion University of the Negev, Israel. He has an extensive background in molecular biology, algae and mammalian cell culture, and animal models. With over a decade of experience in academic lecturing and mentoring, Dmitri has actively participated in academic grants, published multiple high-impact scientific papers, and served as a reviewer. In addition, he has applied his expertise in the industry, consulting for several years with the biomechanics startup MDGo (later SENSA).
Anton Kulaga
R&D, Bioinformatics, Innovation
Anton is a dedicated bioinformatician specializing in synthetic biology, and focusing on the design of genetic constructs for mammals and algae. He has developed his expertise in multi-omics analysis and advanced big data techniques, utilizing machine learning to decipher gene expression patterns. As an active member of the open-source community, Anton contributes to numerous bioinformatics projects. His proficiency is especially prominent in the realm of mammalian synthetic biology. Beyond his laboratory endeavors, Anton is a co-founder of the International Longevity Alliance, where he advocates for global advancements in anti-aging technologies.
Eugen Ursu, MD
R&D, Methodology, Troubleshooting
Eugen is a medical doctor, also studying towards his PhD in Computational Immunology. He has gained substantial experience in cell and synthetic biology through extensive wet lab work. Eugen published several papers in the field of longevity and aging research. His research primarily focuses on gene expression analysis, intercellular communication, and antibody-antigen interactions. In CellFabrik's projects, he has developed extensive expertise in both algae and mammalian cell cultures.
Simona Ghenea, PhD
Senior researcher, Molecular & Synthetic Biology
Simona is a senior researcher at the Institute of Biochemistry of the Romanian Academy, focusing on the degradation of misfolded proteins. She earned her PhD from Hiroshima University, specializing in molecular studies of peroxisome biogenesis and continued with a postdoctoral project at Queen’s University in Kingston, Canada, where her research was centered on the genetics of morphogenesis and cell signaling. With expertise in molecular cell biology, genetics and animal models, she does genetic engineering and synthetic biology, as part of CellFabrik's projects.
Gabriela Chiritoiu, PhD
Senior researcher, Cell Biology & Proteomics
Gabriela is a scientist whose research is focused on protein degradation and antigen processing. She has a PhD in biochemistry and has conducted several academic projects at the Institute of Biochemistry, covering the complex roles of glycosylation in epitope generation and antigen presentation, and deciphering the degradation mechanisms of unfolded proteins associated with the Endoplasmic reticulum, using proteomics (including mass spectrometry and protein analysis) and immunopeptidome analysis. She also has experience with the design, generation and characterization of various tumoral or mesenchymal stem cell lines. At CellFabrik, Gabriela is contributing with her extensive expertise and skills in mammalian cell culture, protein purification and quantitative biochemistry techniques.
Monica Tudor
Junior researcher, Cell Culturing, Biochemistry
Monica is an emerging talent in the field of biochemistry and molecular biology. She completed her Bachelor's and Master’s degrees in Biochemistry at the Faculty of Biology. Currently, she is conducting research toward her PhD at the Institute of Biochemistry, focusing on the development of small molecule inhibitors for the prevention of ovarian cancer. Monica specializes in 3D cell culture, protein expression in cells and tissues, flow cytometry and small molecules screening.
Contact
